title: Diabetes treatment over age 65: Is worse control really better?
authors.affiliation: Icahn School of Medicine at Mount Sinai.
authors.forename: Zachary
authors.initials: Z
authors.lastname: Bloomgarden
authors.affiliation: University of California San Diego.
authors.forename: Christian
authors.initials: C
authors.lastname: Mende
authors.affiliation: University of California San Diego and Scripps Whittier Institute for Diabetes.
authors.forename: Daniel
authors.initials: D
authors.lastname: Einhorn
authors.affiliation: Metabolic Institute of America.
authors.forename: Yehuda
authors.initials: Y
authors.lastname: Handelsman
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D000066491:Clinical Decision-Making; D003920:Diabetes Mellitus / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006304:Health Status; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D007004:Hypoglycemic Agents